Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety

NCT01820143 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Il-Yang Pharm. Co., Ltd.